VHL and cancer: The VHL gene is often mutated in ccRCC cell lines (e.g., 786-O and UM-RC-2) with subsequent activation of the HIF pathway that regulates the expression of various target proteins involved in ccRCC progression; however, the status of VHL alone cannot predict the differential sensitivity of ccRCC to cancer treatments.